Lab Automation in a Post-COVID World: 5 Questions to Ask and Answer
Regardless of how impressive or advanced new lab technology may be, it will not be effective if the people using it aren’t familiar or fully comfortable with it
Coronavirus
InsightsMore Coronavirus Insights
How Did Pharma Firms Develop COVID-19 Vaccines So Quickly?
Government non-dilutive funding set the stage for the production of COVID-19 vaccines
MultimediaMore Coronavirus Multimedia
SurveysMore Coronavirus Surveys
Lab Manager’s 2021 Purchasing Trends Survey
Despite the COVID-19 pandemic, many labs are still thriving and increasing their investments
Product FocusMore Coronavirus Product Focus
How to Choose an Ultralow Freezer for the Lab
What to consider before purchasing an ultralow temperature freezer
ResourcesMore Coronavirus Resources
Critical Disaster Planning Lessons for Laboratories
The COVID-19 pandemic offers an opportunity for lab leaders to reevaluate their preparation strategies
How to Manage Pandemic-Related Changes to the Workplace
As COVID-19 restrictions lift, the new workplace will most likely be a combination of working remotely and at the office
Industry NewsMore Coronavirus Industry News
COVID-19: Vaccine Hesitant in the USA Unlikely to Change Their Minds
Half of those who are unwilling to be vaccinated against SARS-CoV-2 report that nothing will change their mind
Scientists Show Plasma Technology Can Safely Clean Disposable PPE for Reuse
New method can remove 99.99 percent of coronavirus from contaminated face masks
Technology NewsMore Coronavirus Technology News
New RT-LAMP Tests Simplify Infectious Disease Surveillance
RT-LAMP nucleic-acid-based amplification provides a rapid and low-cost option for viral pathogen detection
New Monoclonal Antibodies Added to AMSBIO Portfolio
Two monoclonal antibodies that recognize the Spike RBD (B.1.1.529, Omicron Variant) protein